Journals / Medicine Science / 2020 / Cilt: 9 - Sayı: 4

Evaluation of infections in neurological diseases in a palliative care centre

Pages
993–997
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that prevention and management of infections are important in achieving relatively shorter LOS in PCC considering the chronic and progressive courses of neurologic diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study on neurologic diseases treated in palliative care, we aimed to identify the factors predisposing the sites in the body to develop infections and the factors affecting the quantities of growth in the cultures.
📊
Key Findings & Data:The medical records of patients with neurologic diseases in the palliative care centre (PCC) were retrospectively reviewed covering the years between 2014 and 2018.
💡
Conclusion & Impact:We suggest that prevention and management of infections are important in achieving relatively shorter LOS in PCC considering the chronic and progressive courses of neurologic diseases.
🔬Design:Review & Systematic Survey
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Özet

In this study on neurologic diseases treated in palliative care, we aimed to identify the factors predisposing the sites in the body to develop infections and the factors affecting the quantities of growth in the cultures. The medical records of patients with neurologic diseases in the palliative care centre (PCC) were retrospectively reviewed covering the years between 2014 and 2018. The patient data including the age, gender, length of stay (LOS) in PCC; their diagnoses and comorbid diseases, nutritional status, pressure ulcers (PU) and their emergence; and the quantities of growth in blood, urine, wound, rectal, and tracheal aspirate cultures (TA) were collected and compared. One hundred and forty-three patients were included in the study. The highest quantity of growth was observed in urine cultures. The rates of growth were statistically higher in blood cultures of patients with a percutaneous endoscopic gastrostomy (PEG) and a tracheostomy (p=0.001, p=0.013). The quantities of growth in wound cultures were lower in the cancer patients, whereas, those in the wound and rectal cultures were significantly higher in the patients with PU. The growth quantities were higher in the TA cultures of the patients with hypoxic brain injury and tracheostomies (p=0.033, p<0.001). The rates of growth in the blood, urine, wound, and rectal cultures increased with increasing LOS in PCC. We suggest that prevention and management of infections are important in achieving relatively shorter LOS in PCC considering the chronic and progressive courses of neurologic diseases.

🔖

Cite This Article

AKDOĞAN, D., SARIÇAM, G., KAHVECİ, K. (2020). Evaluation of infections in neurological diseases in a palliative care centre. Medicine Science, Cilt: 9 - Sayı: 4, 993–997. https://ajindex.com/articles/276873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. World Health Organization (WHO). WHO Definition of Palliative CareAvailable at: http://www.who.int/cancer/palliative/definition/en/ access date 30 September 2020
  2. Boersma I, Miyasaki J, Kutner J et al. Palliative care and neurology: time for a paradigm shift. Neurology. 2014;83:561-7
  3. Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage. 2000;20:326-34
  4. Datta, R, Juthani-Mehta M. Burden and management of multidrug-resistant organisms in palliative care. Palliat Care. 2017;10:1178224217749233
  5. Homsi J, Walsh D, Panta R et al. Infectious complications of advanced cancer. Support Care Cancer. 2000;8:487-92
  6. Rosenberg JH, Albrecht JS, Fromme EK et al. Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med. 2013;16:1568-74
  7. Reinbolt RE, Shenk AM, White PH et al. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2005;30:175-82
  8. Baghban A, Juthani-Mehta M. Antimicrobial use at the end of life. Infect Dis Clin North Am. 2017;31:639-47
  9. Juthani-Mehta M., Malani PN, Mitchell SL. Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. Jama. 2015;314:2017-8
  10. Yajima R, Ise Y, Wako T et al. A retrospective study of risk factors for infection in cancer patients receiving specialist palliative care. J Nippon Med Sch. 2013;80:481-5
  11. Rivera-Lara L, Ziai W, Nyquist P. Management of infections associated with neurocritical care. Handb Clin Neurol. 2017;140:365-378
  12. O'Horo JC, Sampathkumar P. Infections in Neurocritical Care. Neurocrit Care. 2017;27:458-67
  13. White PH, Kuhlenschmidt HL, Vancura BG et al. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2003;25:438-43
  14. Schönenberger S, Al-Suwaidan F, Kieser M et al. The SETscore to predict tracheostomy need in cerebrovascular neurocritical care patients. Neurocrit Care. 2016;25:94-104
  15. Allareddy V, Rampa S, Nalliah RP, et al. Prevalence and predictors of gastrostomy tube and tracheostomy placement in anoxic/hypoxic ischemic encephalopathic survivors of in-hospital cardiopulmonary resuscitation in the united states. PLoS One. 2015;10:e0132612
  16. Pignatti P, Balestrino A, Herr C et al. Tracheostomy and related hostpathogen interaction are associated with airway inflammation as characterized by tr